Comparing Octreotide vs Insulin Glargine
Octreotide | Insulin glargine |
|
---|
Octreotide | Insulin glargine |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Diarrhea, Diabetes - Type 1, Dumping Syndrome, Gastrinoma, Glucagonoma, Insulinoma, Pituitary Adenoma, Postural Orthostatic Tachycardia Syndrome, Small... View more |
Prescription only
Prescribed for Diabetes - Type 2, Diabetes - Type 1. insulin glargine may also be used for purposes not listed in this medication guide. |
Related suggestions Diabetes, Type 1
Popular comparisons
|
|||||||||||||||
More about Octreotide | More about Insulin glargine | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Octreotide has an average rating of 7.6 out of 10 from a total of 17 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
Insulin glargine has an average rating of 4.1 out of 10 from a total of 287 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 58% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: octreotide side effects in more detail. |
See also: insulin glargine side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all octreotide prices |
View all insulin glargine prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Bynfezia Pen, Mycapssa, Sandostatin, Sandostatin LAR Depot | Basaglar, Lantus, Lantus SoloStar, Rezvoglar, Semglee, Toujeo Max SoloStar, Toujeo SoloStar | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
1.5 hours |
24 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 155 drugs are known to interact with octreotide:
|
A total of 385 drugs are known to interact with insulin glargine:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
June 26, 2020 |
April 20, 2000 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.